Target intelligence / Profile preview

N-acetylglutamate synthase (NAGS)

Target
NAGS
Molecular classification
Enzyme, N-acetyltransferase family
01

Overview

N-acetylglutamate synthase (NAGS) is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate from glutamate and acetyl-CoA, primarily in the liver[2][1]. N-acetylglutamate is a crucial allosteric activator of carbamoyl phosphate synthase I, the enzyme initiating the urea cycle for effective ammonia detoxification in mammals[1][2][3][4]. In microorganisms and plants, NAGS functions as a key enzyme for arginine biosynthesis[2][3]. Deficiency of NAGS causes a rare inborn error of metabolism—N-acetylglutamate synthase deficiency—resulting in impaired urea cycle function, potentially life-threatening hyperammonemia, and neurological symptoms[1][5]. Treatment with N-carbamylglutamate, a synthetic analog of N-acetylglutamate, can restore urea cycle activity and is an approved therapy for NAGS deficiency[5].

Other names
N-acetylglutamate synthase, mitochondrialN-acetylglutamate synthase long formN-acetylglutamate synthase short formN-acetylglutamate synthase conserved domain formAGASARGANAT7Amino-acid acetyltransferaseN-acetylglutamate synthetase
02

Mechanism of action

Allosteric activation of carbamoyl phosphate synthase I by production of N-acetylglutamate; Restoration of urea cycle function through N-carbamylglutamate supplementation in deficiency

03

Biological functions

Urea cycle regulationNitrogen removalCofactor production for carbamoyl phosphate synthase IRegulation of ammonia detoxificationArginine biosynthesis in microorganisms and plants
04

Disease associations

Urea cycle disordersHyperammonemiaMetabolic disease
05

Safety considerations

Risk of severe hyperammonemia and neurological damage in deficiencyLifelong management neededCaution with drugs affecting NAGS function (e.g., valproic acid)
06

Interacting drugs

N-carbamylglutamate (Carbaglu)
07

Biomarkers

Plasma ammonia levelsPlasma glutamine (elevated in deficiency)Plasma citrulline and arginine (low in deficiency)Genetic testing for NAGS gene mutations

Beyond the preview

Go deeper on N-acetylglutamate synthase (NAGS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetylglutamate synthase (NAGS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call